-
1
المؤلفون: Stephen Begbie, Wendy R. Parulekar, Scott North, Francis Parnis, Alvin Tan, David Pook, John McCaffrey, Xanthi Coskinas, Thean Hsiang Tan, M. Neil Reaume, Scott Williams, Francisco E. Vera-Badillo, Alastair Thomson, Emily Tu, Shahneen Sandhu, Alison Yan Zhang, Andrew J. Martin, Anthony M. Joshua, Lisa G. Horvath, Nicola Jane Lawrence, Margaret McJannett, Wendy Hague, Martin R. Stockler, Ian D. Davis, Christopher Sweeney, Robert Zielinski, Ray McDermott, Mark Frydenberg, Simon Chowdhury, Gavin Marx, Kim N. Chi, Sonia Yip
المصدر: European Urology. 80:275-279
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Urology, 030232 urology & nephrology, Antineoplastic Agents, Androgen deprivation therapy, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Nitriles, Phenylthiohydantoin, medicine, Humans, Enzalutamide, Clinical Trials as Topic, business.industry, Apalutamide, Hazard ratio, Prostatic Neoplasms, Cancer, Androgen Antagonists, Neoplasms, Second Primary, medicine.disease, Interim analysis, Survival Analysis, Prostatic Neoplasms, Castration-Resistant, Thiohydantoins, chemistry, 030220 oncology & carcinogenesis, Benzamides, Hormonal therapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c89e5cd5827a78e84a6994cb6b6b50Test
https://doi.org/10.1016/j.eururo.2021.05.016Test -
2
المؤلفون: Eileen Soulis, Simon Chowdhury, Alison Birtle, Syed A. Hussain, Anna Morris, James Paul, Paula Morrison, Robert Jones, B. Fulton, Thomas Powles, Simon J. Crabb
المصدر: Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Trialsمصطلحات موضوعية: Oncology, Urologic Neoplasms, medicine.medical_specialty, medicine.medical_treatment, Medicine (miscellaneous), Antineoplastic Agents, Targeted therapy, Study Protocol, 03 medical and health sciences, 0302 clinical medicine, Maintenance therapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Clinical endpoint, Urothelial cancer, Humans, Mass Screening, Multicenter Studies as Topic, Pharmacology (medical), Molecular Targeted Therapy, 030212 general & internal medicine, Neoplasm Metastasis, Randomized Controlled Trials as Topic, Carcinoma, Transitional Cell, Chemotherapy, lcsh:R5-920, business.industry, Precision medicine, Cancer, Biomarker, medicine.disease, Progression-Free Survival, United Kingdom, 030220 oncology & carcinogenesis, Biomarker (medicine), business, lcsh:Medicine (General)
وصف الملف: application/pdf; text
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd613596e4e4df1feec9d1e5df6b0e6Test
https://eprints.gla.ac.uk/182451/1/182451.pdfTest -
3
المؤلفون: Simon Chowdhury, Nick van Dijk, Akhila Wimalasingham, Simon Hughes, Bernadett Szabados, Alfonso Gomez de Liano, Thomas Powles, Mark Linch, Michiel S. van der Heijden, S. Rudman, Yen Zhi Tang
المصدر: European Urology. 73:149-152
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Urology, medicine.medical_treatment, Antineoplastic Agents, Disease, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, PD-L1, medicine, Humans, Aged, Retrospective Studies, Aged, 80 and over, Response rate (survey), Carcinoma, Transitional Cell, Chemotherapy, biology, business.industry, Middle Aged, Immune checkpoint, Treatment Outcome, 030104 developmental biology, Urinary Bladder Neoplasms, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Cohort, biology.protein, Female, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5ddc51584f0ed07b23bfe60bd72fa73Test
https://doi.org/10.1016/j.eururo.2017.08.022Test -
4
المؤلفون: Laurence Klotz, Fong Wang, D. Robert Siemens, Ping Lin, Arnauld Villers, Steve van Os, Benoit Baron, Nahla Hasabou, Simon Chowdhury, Neal D. Shore, Axel Heidenreich
المصدر: Journal of Urology. 199:147-154
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Bicalutamide, Urology, 030232 urology & nephrology, Antineoplastic Agents, Tosyl Compounds, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Double-Blind Method, Internal medicine, Nitriles, Phenylthiohydantoin, Post-hoc analysis, medicine, Humans, Enzalutamide, Anilides, Progression-free survival, Adverse effect, Aged, business.industry, Hazard ratio, Age Factors, Middle Aged, Prostate-Specific Antigen, medicine.disease, Progression-Free Survival, Prostatic Neoplasms, Castration-Resistant, Prostate-specific antigen, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Benzamides, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29aa00bb74e7fa1ad63b000377a8489Test
https://doi.org/10.1016/j.juro.2017.08.080Test -
5
المؤلفون: Neeraj Agarwal, Frederique Baton, Patrick Werbrouck, Nicholas J. Vogelzang, Mihai Harza, Robert Huddart, Roberto Pili, Jean Christophe Pouget, Piotr Milecki, Andrew J. Armstrong, Gilberto Schwartsmann, Siobhan Ng, Simon Chowdhury, Arija Brize, Martin Bögemann, Thore Nederman, Nicholas D. James, Olexiy Lyulko, Thomas E. Hutson, Cora N. Sternberg, Remy Delva, A. Thanos, Michael A. Carducci, Enrique Gallardo, Helen Tuvesson, Denis Khvorostenko
المصدر: Journal of Clinical Oncology. 34:2636-2643
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Antineoplastic Agents, Quinolones, Placebo, law.invention, Tasquinimod, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, Humans, Neoplasm Metastasis, Aged, Aged, 80 and over, Random assignment, business.industry, Hazard ratio, Middle Aged, medicine.disease, Surgery, Clinical trial, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, 030220 oncology & carcinogenesis, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f167c78f38a92ee7dc53f05c5083ecd5Test
https://doi.org/10.1200/jco.2016.66.9697Test -
6
المؤلفون: Lauren C. Harshman, Ugo De Giorgi, Kevin Chan, Simon J. Crabb, Ulka N. Vaishampayan, Evan Y. Yu, Guru Sonpavde, Günter Niegisch, Cora N. Sternberg, Joaquim Bellmunt, Ali Reza Golshayan, Yu-Ning Wong, Sylvain Ladoire, Rafael Morales-Barrera, Syed A. Hussain, Ajjai Alva, Jonathan E. Rosenberg, Andrea Necchi, Simon Chowdhury, Matthew I. Milowsky, Gregory R. Pond, Daniel W. Bowles, Aristotelis Bamias, Jack Baniel, Matthew D. Galsky, Srikala S. Sridhar, Marc C. Smaldone, Sandy Srinivas, Dominik Berthold, Neeraj Agarwal, Sumanta K. Pal, Thomas Powles, Christine Theodore, Linda Cerbone, Rosalia Viterbo
المساهمون: Fondazione IRCCS Istituto Nazionale dei Tumori, McMaster University [Hamilton, Ontario], Fox Chase Cancer Center, City of Hope Comprehensive Cancer Center [Duarte], UAB Comprehensive Cancer Center UAB Comprehensive Cancer Center [Birmingham, AL, USA], University of Alabama at Birmingham [ Birmingham] (UAB), Dana-Farber Cancer Institute [Boston], University of Southampton, University of Michigan [Ann Arbor], University of Michigan System, Guy's and St Thomas' Hospital [London], Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Stanford School of Medicine [Stanford], Stanford Medicine, Stanford University-Stanford University, University of Utah School of Medicine [Salt Lake City], National and Kapodistrian University of Athens (NKUA), Rabin Medical Center - Beilinson and Hasharon Hospitals [Petach-Tikva, Israel], Medical University of South Carolina [Charleston] (MUSC), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, San Camillo Forlanini Hospital [Rome], University of Washington [Seattle], Karmanos Cancer Institute, Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], University of Liverpool, Vall d'Hebron Institute of Oncology [Barcelone] (VHIO), Vall d'Hebron University Hospital [Barcelona], University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Hôpital Foch [Suresnes], Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), University of Toronto, Princess Margaret Hospital, Barts & The London School of Medicine, Memorial Sloane Kettering Cancer Center [New York], Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Necchi, A, Pond, Gr, Smaldone, Mc, Pal, Sk, Chan, K, Wong, Yn, Viterbo, R, Sonpavde, G, Harshman, Lc, Crabb, S, Alva, A, Chowdhury, S, De Giorgi, U, Srinivas, S, Agarwal, N, Bamias, A, Baniel, J, Golshayan, Ar, Ladoire, S, Sternberg, Cn, Cerbone, L, Yu, Ey, Bellmunt, J, Vaishampayan, U, Niegisch, G, Hussain, S, Bowles, Dw, Morales-Barrera, R, Milowsky, Mi, Theodore, C, Berthold, Dr, Sridhar, S, Powles, T, Rosenberg, Je, Galsky, Md
المصدر: European Urology Focus
European Urology Focus, Elsevier, 2018, 4 (6), pp.937-945. ⟨10.1016/j.euf.2017.03.011⟩مصطلحات موضوعية: Male, medicine.medical_treatment, 030232 urology & nephrology, Urinary Diversion, 0302 clinical medicine, Robotic Surgical Procedures, Interquartile range, Perioperative chemotherapy, Oncologists, Muscle invasive, Margins of Excision, Middle Aged, Prognosis, Neoadjuvant Therapy, 3. Good health, Survival Rate, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Urothelial carcinoma, medicine.medical_specialty, Urology, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Cystectomy, Article, Disease-Free Survival, 03 medical and health sciences, medicine, Humans, Robot-assisted surgery, Neoplasm Invasiveness, Aged, Proportional Hazards Models, Retrospective Studies, Carcinoma, Transitional Cell, Chemotherapy, Bladder cancer, business.industry, Proportional hazards model, Muscle, Smooth, Retrospective cohort study, medicine.disease, Surgery, Logistic Models, Urinary Bladder Neoplasms, Multivariate Analysis, Lymph Node Excision, Muscle-invasive disease, Lymph Nodes, business
وصف الملف: text
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc30dcb8081be78c359d6685fc6fd8ebTest
https://hal.archives-ouvertes.fr/hal-01697161Test -
7
المصدر: BJU International. 117:721-724
مصطلحات موضوعية: Immunologic Factors, Urology, medicine.medical_treatment, Programmed Cell Death 1 Receptor, 030232 urology & nephrology, Antineoplastic Agents, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Antibodies monoclonal, medicine, Humans, CTLA-4 Antigen, Bladder cancer, business.industry, Antibodies, Monoclonal, Immunotherapy, medicine.disease, Urinary Bladder Neoplasms, 030220 oncology & carcinogenesis, Immunology, BCG Vaccine, business, BCG vaccine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a02347348d7279b2c78fc44d9f61865Test
https://doi.org/10.1111/bju.13330Test -
8
المصدر: Expert Review of Anticancer Therapy. 14:271-277
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Survival, medicine.medical_treatment, Population, Improved survival, Antineoplastic Agents, Nephrectomy, Targeted therapy, Renal cell carcinoma, Internal medicine, medicine, Humans, Pharmacology (medical), Cytoreductive nephrectomy, Neoplasm Metastasis, education, Carcinoma, Renal Cell, education.field_of_study, Performance status, business.industry, Patient Selection, Interferon-alpha, medicine.disease, Combined Modality Therapy, Primary tumor, Kidney Neoplasms, Surgery, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07fa2c9743c26112821712eb1c29f23Test
https://doi.org/10.1586/14737140.2014.864240Test -
9
المؤلفون: Anita Lavery, Clare Gilson, Simon Chowdhury
المصدر: Expert review of anticancer therapy. 16(12)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Disease, Poly(ADP-ribose) Polymerase Inhibitors, Targeted therapy, 03 medical and health sciences, Brca1 2 mutation, Prostate cancer, 0302 clinical medicine, Internal medicine, Medicine, Humans, Pharmacology (medical), Neoplasm Metastasis, business.industry, Prostatic Neoplasms, medicine.disease, Survival Rate, 030104 developmental biology, Docetaxel, 030220 oncology & carcinogenesis, PARP inhibitor, Cancer research, Biomarker (medicine), Poly(ADP-ribose) Polymerases, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ee658946cc3ed29a1bb260e5442546Test
https://pubmed.ncbi.nlm.nih.gov/27686597Test -
10
المصدر: Clinical Nephrology. 79:154-160
مصطلحات موضوعية: Graft Rejection, Male, Nephrology, medicine.medical_specialty, medicine.medical_treatment, Population, Urology, Antineoplastic Agents, Context (language use), urologic and male genital diseases, Malignancy, Renal cell carcinoma, Internal medicine, medicine, Humans, education, Carcinoma, Renal Cell, Sirolimus, education.field_of_study, business.industry, TOR Serine-Threonine Kinases, Cancer, General Medicine, Middle Aged, medicine.disease, Kidney Transplantation, Kidney Neoplasms, Nephrectomy, Radiography, Female, business, Immunosuppressive Agents, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6af9d525a528c3efc27c8dc4154a40eTest
https://doi.org/10.5414/cn107107Test